Journal profile · ENDOCRINOLOGY & METABOLISM
Canadian Journal of Diabetes
ISSN 1499-2671 · eISSN 2352-3840 · Elsevier Inc. · CANADA · Quarterly · Founded 2002
Canadian Journal of Diabetes: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.66; hybrid open access; APC about USD 3,300; median 152 days to acceptance (107 articles, last 24 months); community-reported acceptance: easy; 282 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Canadian Journal of Diabetes is published by Elsevier Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes Management and Research, Diabetes Management and Education and Diabetes Treatment and Management, together about 34.7% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
The Canadian Journal of Diabetes is Canada's only diabetes-oriented, peer-reviewed, interdisciplinary journal for diabetes health-care professionals.Published eight times a year, the Canadian Journal of Diabetes contains original articles; reviews; case reports; shorter articles such as Perspectives in Practice, Practical Diabetes and Innovations in Diabetes Care; Diabetes Dilemmas and Letters to the Editor. The Canadian Journal of Diabetes is distributed as a benefit of membership to all members of the professional section of Diabetes Canada.
From the journal's Aims & Scope
Research area (LetPub): ENDOCRINOLOGY & METABOLISM
Editor-in-chief Jeremy GilbertPublisher website
Editorial board by country: none in mainland China; most named United States 2, Canada 2, Malaysia 2, Switzerland 1 (7 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes Management and ResearchMedicine14.4%
- Diabetes Management and EducationMedicine11.4%
- Diabetes Treatment and ManagementMedicine8.9%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine6.5%
- Pancreatic function and diabetesMedicine5.4%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology5.1%
- Diet and metabolism studiesMedicine4.1%
- Metabolism, Diabetes, and CancerBiochemistry, Genetics and Molecular Biology3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.66LetPub ·
- Impact factor (publisher)
- 2.7Publisher website ·
- CiteScore 2026-06
- 4.7LetPub ·
- CiteScore (publisher)
- 4.7Publisher website ·
- SJR 2026-06
- 0.96LetPub ·
- SNIP 2026-06
- 0.85LetPub ·
- h-index
- 31LetPub ·
- h-index
- 78OpenAlex ·
- i10-index
- 869OpenAlex ·
- 2-year mean citedness
- 0.71OpenAlex ·
- Self-citation rate
- 7.4%LetPub ·
- Share of gold OA articles
- 19.61%LetPub ·
Volume
- Articles per year
- 62LetPub ·
Articles by year OpenAlex count · 6,578 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 88 | 43 | 7 |
| 2025 | 282 | 48 | 130 |
| 2024 | 234 | 43 | 293 |
| 2023 | 498 | 50 | 582 |
| 2022 | 242 | 38 | 1,052 |
| 2021 | 250 | 43 | 1,311 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
152 daysMedian, submission to acceptance · P25–P75 96 days – 231 days
- Acceptance to online
- median 10 days (107 articles)
- Submission to online
- median 161 days
- Sample
- 107 articles with submission and acceptance dates (187 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average acceptance (community reports)
- EasyLetPub ·
- First decision after review
- 68 daysPublisher website ·
- Submission to acceptance
- 128 daysPublisher website ·
- Acceptance to publication
- 7 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,300 / EUR 3,090 / GBP 2,640 / JPY 409,300 | — | — | |
| Publisher website | USD 3,300 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted17, with length limits
- case report1. Original Research2. Review3. Case Reports4. Practical Diabetes5. Perspectives in Practice6. Innovations in Diabetes Care7. Diabetes Dilemma8. Letters to the …main text ≤ 1,000 words
- case reports3. Case Reports (≤1000 words): Case reports should outline a clinical situation that illustrates unique or atypical features or provide a lesson to be learned t…Length not stated
- diabetes dilemma7. Diabetes Dilemmas (≤850 words): This feature is intended to highlight interesting and challenging cases in diabetes.Length not stated
- editorial1. Original Research2. Review3. Case Reports4. Practical Diabetes5. Perspectives in Practice6. Innovations in Diabetes Care7. Diabetes Dilemma8. Letters to the …Length not stated
- innovations in diabetes care6. Innovations in Diabetes Care (≤700 words): Papers in this section review new resources relevant to the care and education of people with diabetes.Length not stated
- letter1. Original Research2. Review3. Case Reports4. Practical Diabetes5. Perspectives in Practice6. Innovations in Diabetes Care7. Diabetes Dilemma8. Letters to the …Length not stated
- letters to the editor1. Original Research2. Review3. Case Reports4. Practical Diabetes5. Perspectives in Practice6. Innovations in Diabetes Care7. Diabetes Dilemma8. Letters to the …Length not stated
- literature review1. Original Research2. Review3. Case Reports4. Practical Diabetes5. Perspectives in Practice6. Innovations in Diabetes Care7. Diabetes Dilemma8. Letters to the …Length not stated
- meta-analysis1. Original Research2. Review3. Case Reports4. Practical Diabetes5. Perspectives in Practice6. Innovations in Diabetes Care7. Diabetes Dilemma8. Letters to the …Length not stated
- original research1. Original Research2. Review3. Case Reports4. Practical Diabetes5. Perspectives in Practice6. Innovations in Diabetes Care7. Diabetes Dilemma8. Letters to the …main text ≤ 4,000 words
- original research article1. Original Research2. Review3. Case Reports4. Practical Diabetes5. Perspectives in Practice6. Innovations in Diabetes Care7. Diabetes Dilemma8. Letters to the …main text ≤ 4,000 words
- perspective1. Original Research2. Review3. Case Reports4. Practical Diabetes5. Perspectives in Practice6. Innovations in Diabetes Care7. Diabetes Dilemma8. Letters to the …main text ≤ 2,000 words
- perspectives in practice5. Perspectives in Practice (≤2000 words): This section provides a format for authors to discuss new programs or services, ideas, insights or practical approach…Length not stated
- practical diabetes4. Practical Diabetes(≤2000 words): Articles under this section should be structured like review articles, be well-referenced and focus on any aspect of the car…Length not stated
- review1. Original Research2. Review3. Case Reports4. Practical Diabetes5. Perspectives in Practice6. Innovations in Diabetes Care7. Diabetes Dilemma8. Letters to the …main text ≤ 5,000 words
- review article1. Original Research2. Review3. Case Reports4. Practical Diabetes5. Perspectives in Practice6. Innovations in Diabetes Care7. Diabetes Dilemma8. Letters to the …main text ≤ 5,000 words
- systematic review1. Original Research2. Review3. Case Reports4. Practical Diabetes5. Perspectives in Practice6. Innovations in Diabetes Care7. Diabetes Dilemma8. Letters to the …Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Preprints, Self-archiving
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Authorship Criteria and Changes to Authorship
The Canadian Journal of Diabetes has adopted the authorship recommendations of the International Committee of Medical Journal Editors (ICMJE) (https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html). Authorship is thus based on the following 4 criteria:Substantial contributions to the conception or design of the work; or the acqui…
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. If there are no conflicts of interest, then plea…
Source ↗Publisher website ·- Publication ethics
Submission declaration of originality Model summary
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint; see https://www.elsevier.com/sharingpolicy).
Source ↗Publisher website ·- License & copyright Copyright
Journal Publishing Agreement upon acceptance Model summary
Upon acceptance of an article, authors will be asked to complete a "Journal Publishing Agreement" (for more information on this and copyright, refer to https://www.elsevier.com/copyright). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a "Journal Publishing Agreement" form or a link to the online version of this agreement.Subscribers may repro…
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Preprints Preprint references
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…
Source ↗Publisher website ·- Self-archiving Green Open Access
Green open access self-archiving after embargo period Model summary
Authors can share their research in a variety of different ways and Elsevier has a number of green open-access options available. We recommend authors see our green open-access page for further information (https://www.elsevier.com/greenopenaccess). Authors can also self-archive their manuscripts immediately and enable public access from their institution's repository after an embargo period. This…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Inc.
- Country or region
- CANADA
- Language
- English
- Frequency
- Quarterly
- Founded
- 2002
- ISSN
- 1499-2671
- Electronic ISSN
- 2352-3840
- Society / sponsor
- Professional Section of Diabetes Canada
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Canadian Journal of Diabetes
What CAS zone is Canadian Journal of Diabetes in?
In the 2025 upgraded edition of the CAS Journal Ranking, Canadian Journal of Diabetes is in Zone 4 of Medicine, and in Zone 4 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Canadian Journal of Diabetes?
The latest impact factor listed by LetPub is 2.66; CiteScore 4.7, h-index 78.
How long does peer review take at Canadian Journal of Diabetes?
Based on the dates recorded on 107 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 152 days (interquartile range 96–231 days); the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Canadian Journal of Diabetes based?
Of the 7 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (2), Canada (2) and Malaysia (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Canadian Journal of Diabetes?
According to LetPub and DOAJ records, Canadian Journal of Diabetes is indexed in SCIE and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is Canadian Journal of Diabetes open access, and what is the APC?
Canadian Journal of Diabetes is a hybrid journal. For open-access publication: APC about USD 3,300.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .